Furthermore, we discovered that plasma membrane SK2 inhibition increased chemoresistance to Taxol® and that KCNN2 mRNA expression level may constitute a prognostic marker for early stages of serous ovarian cancer. Here, KCNN2 is linked to ovarian serous adenocarcinoma.